biotin has been researched along with tirofiban in 1 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (tirofiban) | Trials (tirofiban) | Recent Studies (post-2010) (tirofiban) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 1,210 | 309 | 427 |
| Protein | Taxonomy | biotin (IC50) | tirofiban (IC50) |
|---|---|---|---|
| Integrin subunit alpha 2b | Rattus norvegicus (Norway rat) | 0.13 | |
| Integrin beta-3 | Homo sapiens (human) | 0.1184 | |
| Integrin alpha-V | Homo sapiens (human) | 0.011 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.1225 | |
| Integrin beta-3 | Rattus norvegicus (Norway rat) | 0.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alame, G; Cazenave, JP; Freund, M; Gachet, C; Gaertner, S; Hechler, B; Leguay, C; Petitou, M | 1 |
1 other study(ies) available for biotin and tirofiban
| Article | Year |
|---|---|
The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds.
Topics: Animals; Biotin; Disease Models, Animal; Drug Combinations; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligosaccharides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thromboembolism; Tirofiban; Tyrosine | 2011 |